Pharma Mar | PHM - Debt


Pharma Mar reported EUR51.4M in Debt for its fiscal quarter ending in June of 2025.





Debt Change Date
Akebia Therapeutics USD 46.51M 7.82M Mar/2025
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
Avita Medical AUD 44.59M 1.4M Jun/2025
Dianthus Therapeutics USD 1.28M 45K Sep/2025
Ionis Pharmaceuticals USD 1.23B 192.99M Sep/2025
IQVIA Holdings USD 15.72B 767M Dec/2025
Laboratorios Farma EUR 129.3M 14.89M Jun/2025
Moderna USD 734M 7M Sep/2025
Organon & Co USD 8.83B 68M Sep/2025
Pharma Mar EUR 51.4M 405K Jun/2025
Revvity USD 3.37B 5.86M Sep/2025
Tectonic Therapeutic USD 876K 115K Dec/2024
Viatris USD 14.44B 318.8M Sep/2025
Xeris Pharmaceuticals USD 257.65M 431K Sep/2025